1Y window · 2025-09-23 to 2026-09-23
Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.
Same window as the price chart above
These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.
MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.
Calculated from this company's filed figures, and from the current price where a ratio needs one. Every ratio shows its source trace: the filed elements it reads and the arithmetic behind the result.
P/E = Price / EPS
P/E = Price / (ProfitOrLossAttributableToOwnersOfParent / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) → ₹1,587.90 / (₹-738,030,000 / 114,620,000 shares) = ₹1,587.90 / ₹-6.44 EPS
ROE = Net Income / Shareholder Equity
ROE = ProfitOrLossAttributableToOwnersOfParent / EquityAttributableToOwnersOfParent → ₹-738,030,000 / ₹58,312,890,000 = -1.27%
Debt/Equity = Total Debt / Shareholder Equity
Debt/Equity = BorrowingsCurrent + BorrowingsNoncurrent / EquityAttributableToOwnersOfParent → ₹12,762,960,000 / ₹58,312,890,000 = 0.22
Current Ratio = Current Assets / Current Liabilities
Current Ratio = CurrentAssets / CurrentLiabilities → ₹14,259,400,000 / ₹14,419,690,000 = 0.99
ROCE = EBIT / (Shareholder Equity + Total Debt)
ROCE = ProfitBeforeExceptionalItemsAndTax + FinanceCosts / (EquityAttributableToOwnersOfParent + BorrowingsCurrent + BorrowingsNoncurrent) → ₹401,510,000 / (₹58,312,890,000 + ₹12,762,960,000) = 0.56%
Dividend Yield = (Dividends Paid / Diluted Shares Outstanding) / Price
Qualification This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.
Dividend Yield = (|DividendsPaidClassifiedAsFinancingActivities| / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) / Price → (₹0 / 114,620,000 shares) / ₹1,587.90 = ₹0.00 / ₹1,587.90
Computed from this company's stored annual filings. Each figure carries the filed values behind it as a tooltip.
Needs net profit and CFO for 3+ stored years; only 2 on file.
Eight year-over-year accounting indices (Beneish, 1999) computed for Onesource Specialty Pharma Ltd. across its two most recently stored annual filings. Read the disclosures below before anything past this paragraph.
This is not an accusation and not a finding that any manipulation occurred. Beneish's own paper is explicit that the score identifies companies whose accounting CHARACTERISTICS resemble those of a sample of past manipulators -- nothing more. StockProof never labels a company "manipulator", "red flag" or "suspicious", and never shows any list of companies ordered by this score. The eight components below -- factual statements about figures the company itself filed -- always come before the composite number, which is the inference, not the fact.
The M-Score is calibrated on 74 US-listed companies from 1982-1992 later found to have manipulated earnings (Beneish, M. D. (1999), "The Detection of Earnings Manipulation", Financial Analysts Journal 55(5)) -- not on any Indian company or era. Measured on StockProof's own Nifty 500 universe as of 2026-09-02, 13.6% of companies score above Beneish's own published cutoff. On any realistic base rate of actual earnings manipulation, that flag rate is overwhelmingly false positives, not overwhelmingly real ones.
No "Selling, General & Administrative Expense" element exists anywhere in NSE's filed data. The SGAI component below is approximated as Employee Benefit Expense + Other Expenses, divided by revenue -- a reasonable stand-in for a manufacturer, but for a services company this proxy is closer to the entire cost base than to SG&A specifically. This is disclosed because it is a genuine deviation from Beneish's published specification; its coefficient (-0.172) is the smallest of the eight, which bounds how far the approximation can move the composite.
This measures something different from a financial-distress score like Altman's Z-Score, and the two essentially never agree. Measured on StockProof's own 389-company overlap as of 2026-09-02: only 5 companies were flagged by both, an agreement rate (intersection ÷ union) of 6.2%, and a correlation between the two scores of +0.088 -- closely matching the independently measured +0.092 over 3,242 Malaysian-listed companies. A low Z-Score and a high M-Score are not corroborating each other; they are unrelated measurements.
Comparing FY2024-25 → FY2025-26
| Index | Value | Beneish's own threshold | Reading, vs. that threshold |
|---|---|---|---|
| DSRI — Days' Sales in Receivables Index | 1.684 | 1.031 | Exceeds Beneish's published threshold |
| GMI — Gross Margin Index | 1.017 | 1.014 | Exceeds Beneish's published threshold |
| AQI — Asset Quality Index | 0.968 | 1.039 | Below Beneish's published threshold |
| SGI — Sales Growth Index | 0.984 | 1.134 | Below Beneish's published threshold |
| DEPI — Depreciation Index | 1.010 | 1.077 | Below Beneish's published threshold |
| SGAI — SG&A Index | 1.258 | 1.041 | Exceeds Beneish's published threshold |
| LVGI — Leverage Index | 1.384 | 1.111 | Exceeds Beneish's published threshold |
| TATA — Total Accruals to Total Assets | -0.010 | 0.018 | Below Beneish's published threshold |
This is a reading against a published statistical model, not a finding and not a verdict on this company -- see the disclosures above, especially how this compares to a general population's own measured false-positive rate.
8 stored quarters
| Metric (to shareholders basis) | Q2 FY2024-25 | Q3 FY2024-25 | Q4 FY2024-25 | Q1 FY2025-26 | Q2 FY2025-26 | Q3 FY2025-26 | Q4 FY2025-26 | Q1 FY2026-27 | Source |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹67.98 Cr. | ₹392.56 Cr. | ₹425.95 Cr. | ₹327.27 Cr. | ₹375.76 Cr. | ₹290.34 Cr. | ₹428.22 Cr. | ₹449.02 Cr. | RevenueFromOperations |
| Net Profit | ₹-39.33 Cr. | ₹-68.85 Cr. | ₹98.20 Cr. | ₹-0.19 Cr. | ₹10.48 Cr. | ₹-88.70 Cr. | ₹4.60 Cr. | ₹25.00 Cr. | ProfitLossForPeriod |
Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10).
Latest filing Jun 2026 · 8 filings on file
| Metric | Dec 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoter & Promoter Group | 37.77% | 37.77% | 34.25% | 29.79% | 29.77% | 29.93% | 30.48% | 30.48% |
| Public | 62.23% | 62.23% | 65.75% | 70.21% | 70.23% | 70.07% | 69.52% | 69.52% |
| Employee Trusts | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoter vs. public shareholding, from NSE's own quarterly shareholding-pattern filings. This is the headline promoter/public split only — a further breakdown by FII/DII/mutual fund holders requires each filing's own detailed disclosure and isn't shown here.
20 trading days shown
| Date | Traded Qty | Delivery Qty | Delivery % |
|---|---|---|---|
| 2026-09-23 | 158650 | 101062 | 63.70% |
| 2026-09-22 | 155059 | 86875 | 56.03% |
| 2026-09-21 | 319894 | 175997 | 55.02% |
| 2026-09-18 | 335793 | 180620 | 53.79% |
| 2026-09-17 | 121361 | 70636 | 58.20% |
| 2026-09-16 | 143256 | 57923 | 40.43% |
| 2026-09-15 | 724751 | 362382 | 50.00% |
| 2026-09-11 | 919086 | 350793 | 39.84% |
| 2026-09-10 | 247132 | 131052 | 53.03% |
| 2026-09-09 | 2411313 | 964771 | 40.01% |
| 2026-09-08 | 707456 | 267998 | 37.88% |
| 2026-09-07 | 140096 | 87480 | 62.44% |
| 2026-09-04 | 112994 | 57619 | 50.99% |
| 2026-09-03 | 118656 | 57222 | 48.23% |
| 2026-09-02 | 136288 | 63290 | 46.44% |
| 2026-09-01 | 69898 | 34056 | 48.72% |
| 2026-08-31 | 98831 | 50782 | 51.38% |
| 2026-08-28 | 32479 | 14390 | 44.31% |
| 2026-08-27 | 315066 | 185796 | 58.97% |
| 2026-08-26 | 130037 | 65956 | 50.72% |
Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero.
16 disclosures shown
| Disclosed | Person | Category | Type | Mode | Quantity | Value (₹) | Resulting stake | Source |
|---|---|---|---|---|---|---|---|---|
| 06 Feb 2026 | PRONOMZ VENTURES LLP | Promoter Group | Buy | Market Purchase | 33906 | 40484442 | 2.37% | XBRL |
| 06 Feb 2026 | Tenshi Pharmaceuticals Private Limited | Promoters | Buy | Market Purchase | 75000 | 87133500 | 18.15% | XBRL |
| 06 Feb 2026 | TENSHI PHARMACEUTICALS PRIVATE LIMITED | Promoters | Buy | Market Purchase | 205000 | 238775533 | 18.33% | XBRL |
| 06 Feb 2026 | PRONOMZ VENTURES LLP | Promoter Group | Buy | Market Purchase | 45000 | 50950494 | 2.41% | XBRL |
| 06 Feb 2026 | TENSHI PHARMACEUTICALS PRIVATE LIMITED | Promoters | Buy | Market Purchase | 85000 | 10208119 | 18.40% | XBRL |
| 06 Feb 2026 | Tenshi Pharmaceuticals Private Limited | Promoters | Buy | Market Purchase | 200000 | 20779011 | 18.09% | XBRL |
| 16 Jun 2025 | Pronomz Ventures LLP | Promoter Group | Sell | Off Market | 5102548 | 10087737396 | 2.34% | XBRL |
| 10 Feb 2025 | Sajitha Pillai | Promoter Group | Sell | Market Sale | 5000 | 7739200 | 0.03% | XBRL |
| 06 Feb 2025 | Padmakumar Karunakaran Pillai | Promoter Group | Sell | Market Sale | 50000 | 77936343 | 0.04% | XBRL |
| 06 Feb 2025 | Vineetha Mohankumar Pillai | Promoter Group | Sell | Market Sale | 47500 | 74355589 | 0.04% | XBRL |
| 06 Feb 2025 | Hemalatha Pillai | Promoter Group | Sell | Market Sale | 12000 | 18955497 | 0.02% | XBRL |
| 06 Feb 2025 | Pronomz Ventures LLP | Promoter Group | Sell | Market Sale | 582524 | 899999580 | 6.80% | XBRL |
| 06 Feb 2025 | Tenshi Pharmaceuticals Private Limited | Promoters | Sell | Market Sale | 3300970 | 5056240975 | 17.94% | XBRL |
| 06 Feb 2025 | Neeraj Sharma | Director | Sell | Market Sale | 20000 | 29742950 | 0.12% | XBRL |
| 06 Feb 2025 | Hemalatha Pillai | Promoter Group | Sell | Market Sale | 18000 | 26155310 | 0.00% | XBRL |
| 06 Feb 2025 | Sajitha Pillai | Promoter Group | Sell | Market Sale | 7500 | 11490425 | 0.03% | XBRL |
SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell.
FY2025-26 · Annual filing
The raw filing line items behind the figures on this page, and NSE's own filing document where NSE publishes one.
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| Line item | Filed value |
|---|---|
| ProfitOrLossAttributableToOwnersOfParent | -738030000.0 |
| PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital | 114620000.0 |
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| Line item | Filed value |
|---|---|
| CurrentAssets | 14259400000.0 |
| CurrentLiabilities | 14419690000.0 |
| EquityAttributableToOwnersOfParent | 58312890000.0 |
| BorrowingsCurrent + BorrowingsNoncurrent | 12762960000.0 |
One MarketDeck account across StockProof, Charting and F&O.
Continue with MarketDeck Create account